Andrea Ellis Bridge Bio Pharma, Inc. (BBIO) insider trading activity

Andrea Ellis is of BridgeBio Pharma, Inc.. Currently has a direct ownership of 18,589 shares of BBIO, which is worth approximately $956,775. The most recent transaction as insider was on Aug 05, 2025, when has been sold 17,167 shares (Common Stock) at a price of $49.0 per share, resulting in proceeds of $841,183. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.6K

54.91% 3M change

54.91% 12M change

Total Value Held $956,775

Andrea Ellis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 05 2025	SELL Open market or private sale	$841,183 $49.0 p/Share	17,167 Reduced 48.01%	18,589 Common Stock
Aug 05 2025	BUY Exercise of conversion of derivative security	$287,547 $16.75 p/Share	17,167 Added 32.44%	35,756 Common Stock
Jun 20 2025	BUY Grant, award, or other acquisition	-	6,589 Added 26.17%	18,589 Common Stock
Apr 14 2025	SELL Open market or private sale	$350,000 $35.0 p/Share	10,000 Reduced 45.45%	12,000 Common Stock
Apr 14 2025	BUY Exercise of conversion of derivative security	$84,500 $8.45 p/Share	10,000 Added 31.25%	22,000 Common Stock
Apr 01 2025	SELL Open market or private sale	$1,021,499 $34.05 p/Share	30,000 Reduced 71.43%	12,000 Common Stock
Apr 01 2025	BUY Exercise of conversion of derivative security	$253,499 $8.45 p/Share	30,000 Added 41.67%	42,000 Common Stock
Mar 15 2022	BUY Open market or private purchase	$100,680 $8.39 p/Share	12,000 Added 50.0%	12,000 Common Stock

Andrea Ellis

Palo Alto, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO

Account